The Business Research Company has updated all its market reports with the latest information for the year 2024, projecting trends and forecasts until 2033.
The Intravenous Immunoglobulin Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Intravenous Immunoglobulin Market:
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
According to The Business Research Company’s Intravenous Immunoglobulin Global Market Report 2024, The intravenous immunoglobulin market size has grown strongly in recent years. It will grow from $13.82 billion in 2023 to $14.84 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to treatment of primary immunodeficiency disorders , management of neurological disorders, rising geriatric population, advancements in plasma fractionation techniques, expanded indications in neurology, treatment of infectious diseases, pediatric immunodeficiency treatment.The intravenous immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $20.24 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%.
The increasing geriatric population is expected to drive the intravenous immunoglobulin market. The geriatric population, comprising individuals aged 65 and older, often experiences a decline in immune function, resulting in a reduced production of antibodies. Intravenous immunoglobulins are essential for providing these individuals with the necessary antibodies to enhance their immune response. This growing demand for intravenous immunoglobulins is a key factor propelling the market forward.For example, the Elderly in India 2021 report by the National Statistical Office (NSO) indicated that in 2021, there were 138 million elderly people in India, and this number is expected to rise to 194 million by 2031. Additionally, according to the World Health Organization (WHO), by 2030, 1 in 6 people globally will be 60 years or older, and the total number of people over 60 years is projected to increase to 1.4 billion by 2030, up from 1 billion in 2020. As a result, the increasing geriatric population is anticipated to drive the growth of the intravenous immunoglobulin market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8538&type=smp
The intravenous immunoglobulin market covered in this report is segmented –
1) By Type: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications
4) By End-User: Hospitals, Clinics, Home Care
Top Major Players
Bio Products Laboratory Limited,
Biotest AG,
China Biologic Products Holdings Inc.,
CSL Behring, Grifols S.A.,
Kedrion SpA
The intravenous immunoglobulin market report table of contents includes:
1. Executive Summary
- Intravenous Immunoglobulin Market Characteristics
- Intravenous Immunoglobulin Market Trends And Strategies
- Intravenous Immunoglobulin Market – Macro Economic Scenario
- Global Intravenous Immunoglobulin Market Size and Growth
- Intravenous Immunoglobulin Market Segmentation
- Intravenous Immunoglobulin Market Regional And Country Analysis
…………..
- Key Mergers And Acquisitions In The Intravenous Immunoglobulin Market
- Intravenous Immunoglobulin Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Intravenous Immunoglobulin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Intravenous Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Intravenous Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………..
Table 75: Bio Products Laboratory Limited Financial Performance
Table 76: Biotest AG Financial Performance
Table 77: China Biologic Products Holdings Inc. Financial Performance
Table 78: CSL Behring Financial Performance
Table 79: Grifols S.A. Financial Performance
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
